<DOC>
	<DOC>NCT00592176</DOC>
	<brief_summary>The purpose of this study is to determine whether local injection of bevacizumab might halt and or cause regression of pterygium growth. This may enable earlier treatment and prevention of pterygium growth into the patient's line of sight thereby limiting the need for surgery and improving quality of life for patients with pterygia.</brief_summary>
	<brief_title>The Effect of Bevacizumab (Avastin) on Pterygium</brief_title>
	<detailed_description />
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>19 years of age and older Diagnosis of pterygia healthy enough to make scheduled followup visits Women of childbearing potential and males who plan to father a child during their participation in the study will be excluded from the study.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>